A State of Revision: USP's Guideline for the Submission of Requests for Revision

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2003
Volume 27
Issue 12

USP's new guideline will assist the industry to help set the monograph standards by which the industry must abide. This column suggests how to apply the guideline to gain maximum benefit.

External Link - article-78319.pdf

Articles in this issue
December 2003
All Signs Indicate a Strong 2004 for Contract Services
Behavior of Uptake of Moisture by Drugs and Excipients
A State of Revision: USP's Guideline for the Submission of Requests for Revision
Targeted Cationic Liposomes, Technologies, and Developments
Sixth Annual International Employment Survey: Staying the Course
Drug Pricing Concerns Shape Policy Decisions in 2003
In the Spotlight--January 2004
December 2003
Recent Videos
Roger Viney, PhD, chief commercial officer for ICE Pharma
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Endo Recalls Adrenalin Chloride Solution

Susan Haigney
December 23rd 2024
Article

The company is voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1 mg/mL) 30 mL vials due to misleading labeling and its status as an unapproved drug.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Patrick Lavery
October 30th 2024
Podcast

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

Site Logo

Lonza's Commitment to the Future (Dec 2024)

Lonza
December 20th 2024
Article

Meeta B. Kratz (Global Vice President, Product Management & Marketing, Lonza Capsule and Health Ingredients) talks about Lonza's future and how that works in tandem to meet client needs.

Site Logo

Development Process for Transforming a Liquid Protein Solution into a Solid Oral Dosage Form

Bend BioScience
December 20th 2024
Article

A case study in converting a solution formulation of a protein into an oral solid dosage form utilizing a fluid bed granulation process and some of the complexities involved.